Patents for C12P 17 - Preparation of heterocyclic carbon compounds with only o, n, s, se, or te as ring hetero atoms (13,366)
05/2005
05/06/2005WO2005040373A1 Immobilization of biocatalyst
05/06/2005WO2005040107A2 Methods for making simvastatin and intermediates
05/06/2005CA2543348A1 Methods for making simvastatin and intermediates
05/06/2005CA2540251A1 Immobilization of biocatalyst
05/05/2005US20050096229 Biocidal compounds and their preparation
05/04/2005EP1404663B1 Eurotinone and derivatives thereof, method for the production and use of the same
05/04/2005EP0941227B9 Epothilone d, production process, and its use as cytostatic as well as phytosanitary agent
05/04/2005CN1613011A Signal system and elements used therein
05/04/2005CN1199959C Percyquuinnin, process for its production and its use pharmaceutical
04/2005
04/28/2005WO2005038036A1 Method for transforming epoxy carrier of trifluoromethyl groups
04/28/2005WO2005038009A2 Production of tacrolimus (fk-506) using new streptomyces species
04/28/2005WO2005038008A1 A method for preparing a fermentation product of soybean having enriched #-aminobutyric acid and phytoestrogens using the bifidobacterium breve k-110 of korean-type lactic acid bacteria
04/28/2005WO2005037813A1 A compound, the preparation and the use thereof
04/28/2005US20050090645 Novel alcohol/aldehyde dehydrogenases
04/28/2005US20050090535 Epothilones C, D, E and F, preparation and compositions
04/28/2005US20050090461 Synthesizing polyketide fusion protein comprising acyltransferase domain for use as anthelminthic, insecticide, antitumor, immunosuppressant, fungicidal and/or bactericidal agents
04/28/2005US20050089987 Polyacryamide beads containing encapsulated cells
04/28/2005US20050089978 Solvent extraction of lipstatin from the fermenation broth uisng multi solvent extraction
04/28/2005US20050089973 Methods and microorganisms for production of panto-compounds
04/28/2005US20050089972 Production of porphyrins
04/28/2005US20050089884 Genes coding for ketosynthase, acyl transferase, acyl carrier protein, ketoreductase, dehydratase and enoyl reductase domains, and genes coding for modifier enzymes, such as ABC transporter, cytochrome P450 monooxygenase, ferredoxin, thioesterase, 4-amino-4-deoxychorismate (ADC) synthase or lyase
04/27/2005EP1525303A1 Genes from propionibacterium freudenreichii encoding enzymes involved in vitamin b12 biosynthesis
04/27/2005CN1610749A Process for production of glutamic acid derivatives
04/27/2005CN1609225A Method of processing fermented erythromycin liquid with modified chitosan
04/27/2005CN1198940C Fermentation of clavulanic acid at a controlled level of ammonia
04/26/2005US6884608 Isolated nucleic acid sequences and polypeptides encoded thereby for epothilone B hydroxylase and mutants and variants and ferredoxin or variants or mutants
04/20/2005EP1524318A1 Genes and proteins for the biosynthesis of polyketides
04/20/2005CN1608052A Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
04/20/2005CN1607245A High efficiency fermentation method for pristinamycin
04/19/2005US6881341 Method for separating lactone-containing high-molecular weight compounds
04/14/2005WO2005033305A1 PROCESS FOR PRODUCING INTERMEDIATE OF USEFUL ALKALOID BIOSYNTHESIS ACCORDING TO RNAi METHOD
04/14/2005WO2005033076A1 Method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds
04/14/2005US20050080277 reacting an enolates with 3-hydroxy-G-butyrolactone, to give dihydroxyoxohexanoic acids,then acylation, reducing with microorganisms, acetalization in the presence of an acid catalyst and solvolysis, to form chemical intermeadiates of 3-hydroxyl-3-methylglutaryl-coenzyme A reductase inhibitors
04/14/2005US20050080276 Process for producing lactone
04/14/2005US20050080267 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
04/14/2005US20050080247 Leinamycin biosynthesis gene cluster and its components and their uses
04/14/2005US20050079498 Expression vector comprising nucleotide sequences coding polypeptide associated with clavam compounds for use in transformation and generation of cells with improved clavulanic acid production
04/14/2005CA2538918A1 Process for producing intermediate of useful alkaloid biosynthesis according to rnai method
04/13/2005EP1522589A1 Composition comprising pravastatin
04/13/2005EP1521828A2 Production of polyketides
04/13/2005EP1521765A1 Bafilomycin-like metabolite from a novel micromonospora species
04/13/2005CN1196793C Process for preparation of dihydroxy esters and derivatives thereof
04/13/2005CN1196789C Modified cytochrome P450 monooxygenases
04/13/2005CN1196698C Epothilone C. D. E and F, production process, and their use as cytostatic as well as phytosanitary agents
04/12/2005CA2214665C Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same
04/07/2005WO2005030944A1 A gene encoding an enzyme for catalyzing biosynthesis of lignan, and use thereof
04/07/2005CA2540367A1 An enzyme for catalyzing biosynthesis of piperitol and/or sesamin
04/06/2005EP1520025A2 Nucleic acid molecules involved in the synthesis of melithiazols
04/06/2005EP1470116A4 Preparation of orlistat and orlistat crystalline forms
04/06/2005EP1244776B1 Tetrahydropyrimidine oxygenase gene, polypeptides encoded by said gene and method for producing the same
04/06/2005CN1195760C Method for separating lactone-contg. high-molecular weight compounds
04/06/2005CN1195750C Recovery of isoflavones from soy molasses
04/05/2005US6875861 Process for producing nitrosonium ions
03/2005
03/31/2005US20050070519 Cyclisation process for the preparation of c-2 beta-lactam compounds
03/31/2005US20050069920 Using encapuslated gene sequences as tools for directed evolution of nucleic acids; microencapsulation and gene expression
03/31/2005US20050069560 Immunosuppressant prodigiosin; pure culture; transplatation of organs, tissues
03/30/2005EP1517993A2 Selective functionalization of hydrocarbons with isolated oxygenases and mediator-based regeneration
03/30/2005EP1115881B1 Process for the enzymatic kinetic resolution of 3-phenylglycidates by transesterification with aminoalcohols
03/30/2005EP1026988A4 Novel fluorescent reporter molecules and their applications including assays for caspases
03/29/2005US6872815 Nucleic acid sequences to proteins involved in tocopherol synthesis
03/29/2005US6872747 Decalactones, method for making, and pharmaceuticals there from
03/24/2005WO2005026373A1 Enzymatic synthesis of enatiopure intermediates by means of cholesterolesterase from yeasts
03/24/2005WO2005025490A2 Novel polyol macrolide antitumor-antibiotics from the novel marine actinomycete strain cnq140
03/24/2005US20050065204 Process for the preparation of enantiopure pyrrolidin-2-one derivatives
03/24/2005US20050064566 an improved process for isolation of (HMG)-CoA reductase inhibitors; comprises a step of reacting the isolated (HMG)-CoA reductase inhibitor with an organic or inorganic cation source to generate a salt form of the inhibitor
03/24/2005CA2539037A1 Enzymatic synthesis of enatiopure intermediates by means of cholesterolesterase from yeasts
03/23/2005EP1516046A2 Genes encoding baeyer-villiger monooxygenases
03/23/2005EP1515974A2 Novel maxi-k channel blockers, methods of use and process for making the same
03/22/2005US6870038 Isolation and expression of a gene for a nitrilase from Acidovorax facilis 72W
03/17/2005WO2005023788A1 Fki-1366 substances and process for producing the same
03/17/2005WO2004090094A3 L-carnitin dehydrogenases, their derivatives and method for producing substituted (s) alkanols
03/17/2005US20050059725 Treating schizophrenia or Parkinson's disease with thiolutin dioxide
03/17/2005US20050059616 administering flavonoids and optionally vitamin E or excipients for the prophylaxis of bone or cardiovascular disorders, headaches, hypertension, cancers, leukemia, arteriosclerosis, Alzheimer's disease, inflammatory diseases, rheumatic diseases, acne, alopecia or psoriasis
03/16/2005EP1514863A1 Process for the purification of pravastatin
03/16/2005EP1514862A1 Process for purification of pravastatin
03/16/2005EP1513940A2 Methods and materials for the production of lactic acid in yeast
03/16/2005EP1513939A2 Fermentation process using specific oxygen uptake rates as a process control
03/16/2005EP1513923A2 Methods and materials for the production of d-lactic acid in yeast
03/16/2005EP1513847A2 Crystallization and purification of macrolides
03/16/2005EP1318824B1 Extracts from the fungus guignardia sp., their uses in pharmaceutical compositions, new isolate compound from the extract of the fungus guignardia sp. and its use in pharmaceutical compositions
03/16/2005EP0904400B1 Enzymatic process for stereoselective preparation of therapeutic amides
03/10/2005WO2005021586A2 Metabolic engineering of viomycin biosynthesis
03/10/2005WO2005020883A2 Methods for the production of ansamitocins
03/10/2005US20050054809 Continuous bioreactor process for the preparation of polyester cyclic oligomers
03/10/2005US20050053927 Rifamycin biosynthesis gene cluster
03/09/2005EP1512402A1 Inhibitors against complex ii of electron transport system
03/09/2005EP1412346B1 Method for producing novel spinosyn derivatives
03/09/2005CN1592788A Production of alpha-keto butyrate
03/09/2005CN1590555A Hydroxylation of compactin to pravastatin by micromonospora
03/09/2005CN1590554A Ketone compound and its preparation method and application
03/09/2005CN1590546A DNA fragments containing biotin biosynthetase gene and use of the same
03/09/2005CN1192107C 5S clavate alkyl gene separated from rhabdion streptomycete and its application in clavulanic acid production
03/03/2005WO2005019426A2 Gene cluster for fostriecin biosynthesis
03/03/2005WO2004099174A3 Continuous bioreactor process for the preparation of polyester cyclic oligomers
03/03/2005WO2004092389A3 New process for improving the manufacture of clavams e.g. clavulanic acid
03/03/2005WO2004089958B1 Crystallization and purification of macrolides
03/03/2005WO2003099219A3 Bryostatins, bryopyrans and polyketides: compositions and methods
03/03/2005US20050050589 Soya cell strains with high isoflavone content
03/03/2005US20050049279 Sustained release daily dosage form comprising D-threo methylphenidate; substantially free of L-threo and erythro optical isomers; minimizing side effects, increasing efficacy
03/03/2005US20050048633 Novel carbonyl reductase, gene encoding the same, and process for producing optically active alcohols using the same
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 134